the-scientist.com

Precision neurotherapeutics aim to improve mental healthcare beyond classic psychedelic approaches by using more targeted, individualized brain or circuit interventions. The focus is on next-generation strategies designed to enhance therapeutic effects while reducing variability, side effects, and the need for trial-and-error dosing. This includes moving toward treatments guided by more specific neurobiological mechanisms rather than broad symptom relief. The broader implication is that mental health drug development is shifting toward personalization and mechanism-based targeting, positioning non-psychedelic and precision-oriented neuromodulation or neuropharmacology as complementary paths for improving clinical outcomes.